Use the hyperlinks, where available to access additional clinical trial information.
APOLLO-B: A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
This is a randomised, quadruple blinded study with two arms. In the Experimental Arm, participants will be administered multiple doses of patisiran, administered via intravenous (IV) infusion. In the Placebo Comparator Arm, participants will be administered the placebo (normal saline) via IV.